Ranjit S. Bhardwaj
Ranjit S. Bhardwaj has specialized in cellular and molecular pathology after studying biomedical sciences in the fields of immunology, immunobiology of cancer, and regenerative medicine. For over 40 years, he has been studying the role of phytomedicine in bridging ancient and modern medicine, including the manufacturing of Polyherbal Metabolite Compounds (PHMC) from medicinal cannabis and herbs. He works as a CEO, shareholder, and adviser in biotech and pharma companies, developing therapeutics for diseases such as diabetes-2 and diabetes-1, Inflammatory bowel disease (IBD), skin inflammatory indications, insomnia, and depression.